Modulation of p53 expression in cultured colonic adenoma cell lines by the naturally occurring lumenal factors butyrate and deoxycholate

International Journal of Cancer

Volumn 73, Issue 5, 1997, Pages 702-706

  Palmer, D Gail ^a   Paraskeva, Christos ^a   Williams, Ann C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CHOLAGOGUE; DEOXYCHOLIC ACID; MESSENGER RNA; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ADENOMA; ARTICLE; CELL CULTURE; CELL DIVISION; COLON TUMOR; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ADENOMA; BUTYRIC ACID; BUTYRIC ACIDS; CELL DIVISION; CHOLAGOGUES AND CHOLERETICS; COLONIC NEOPLASMS; DEOXYCHOLIC ACID; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTAMINE ANTAGONISTS; HUMANS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031588377     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971127)73:5<702::AID-IJC15>3.0.CO;2-7     Document Type: Article

References (36)

1. AVERY, A., PARASKEVA, C., HALL, P., FLANDERS, K.C., SPORN, M. and MOORGHEN, M., TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Brit. J. Cancer, 68, 137-139 (1993).
2. BAKER, S.J., PREISINGER, A.C., JESSUP, J.M., PARASKEVA, C., MARKOWITZ, S., WILLSON, J.K.V., HAMILTON, S. and VOGELSTEIN, B., p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722 (1990).
3. BANKS, L., MATLASHEWSKI, G. and CRAWFORD, L., Isolation of human-p53-specific monoclonal-antibodies and their use in the studies of p53 expression. Europ. J. Biochem., 159, 529-534 (1986).
4. BARTRAM, H.-P., SCHEPPACH, W., SCHMID, H., HOFMANN, A., DUSEL, G., RICHTER, F., RICHTER, A. and KASPER, H., Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia and pH. Cancer Res., 53, 3283-3288 (1993).
5. BOUCK, N., p53 and angiogenesis. Biochim. biophys. Acta, 1287, 63-66 (1996).
6. CHEN, X., KO, L.J., JAYARAMAN, L. and PRIVES, C., p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumour cells. Genes Develop., 10, 2438-2451 (1996).
7. CHIN, K.-V., UEDA, K., PASTAN, I. and GOTTESMAN, G., Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science, 255, 459-462 (1992).
8. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER, M.L. and WYLLIE, A.H., Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362, 849-852 (1993).
9. CRAVEN, P.A., PFANSTIEL, J., SAITO, R. and DE RUBERTIS, F.R., Relationship between loss of rat colonic surface epithelium induced by deoxycholate and initiation of the subsequent proliferative response. Cancer Res., 46, 5754-5759 (1986).
10. CUMMINGS, J.H., POMARE, E.W., BRANCH, W.J., NAYLOR, C.P.E. and MACFARLANE, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28, 1221-1227 (1987).
11. DITTMER, D., PATI, S., ZAMBETTI, G., CHU, S., TERESKY, A.K., MOORE, M., FINLAY, C. and LEVINE, A.J., Gain of function mutations in p53. Nature (Genet.). 4, 42-46 (1993).
12. GOPE, R. and GOPE, M.L., Effect of sodium butyrate on the expression of retinoblastoma (RB1) and p53 gene und phosphorylation of retinoblastoma protein in human colon tumor cell line HT29. Cell mol. Biol., 39, 589-597 (1993).
13. GRAEBER, T.G., OSMANIAN, C., JACKS, T., HOUSMAN, D.E., KOCH, C.J., LOWE, S.W. and GIACCIA, A.J., Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379, 88-91 (1996).
14. HAGUE, A., DÍAZ, G.D., HICKS, D.J., KRAJEWSKI, S., REED, J.C. and PARASKEVA, C., bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int. J. Cancer 72, 898-905 (1997).
15. HAGUE, A., ELDER, D.J.E., HICKS, D.J. and PARASKEVA, C., Apoptosis in colorectal tumour cells: induction by the short-chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer, 60, 400-406 (1995).
16. HAGUE, A., MANNING, A.M., HANLON, K.A., HUSCHTSCHA, L.I., HART, D. and PARASKEVA, C., Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer, 55, 498-505 (1993).
17. HEERDT, B.B., HOUSTON, M.A. and AUGENLICHT, L.H., Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res., 54, 3288-3294 (1994).
18. KANDELL, R.L. and BERNSTEIN, C., Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutrition Cancer, 16, 227-238 (1991).
19. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN B. and CRAIG, R.W., Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991).
20. KNIPPSCHILD, U., OREN, M. and DEPPERT, W., Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene, 12, 1755-1765 (1996).
21. KO, L.J. and PRIVES, C., p53: puzzle and paradigm. Genes Develop., 10, 1054-1072 (1996).
22. KUERBITZ, S.J., PLUNKETT, B.S., WALSH, W.V. and KASTAN, M.B., Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. nat. Acad. Sci. (Wash.), 89, 7491-7495 (1992).
23. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Develop., 10, 934-947 (1996).
24. MATHESON, H., BRANTING, C., RAFTER, I., OKRET, S. and RAFTER, J., Increased c-fos mRNA and binding to the AP-1 recognition sequence accompanies the proliferate response to deoxycholate of HT29 cells. Carcinogenesis, 17, 421-426 (1996).
25. MOLL, U.M., RIOU, G. and LEVINE, A.J., Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. nat. Acad. Sci. (Wash.), 89, 7262-7266 (1992).
26. MOMAND, J., ZAMBETTI, G.P., OLSON, D.C., GEORGE, D. and LEVINE, A.J., The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69, 1237-1245 (1992).
27. MOSNER, J., MUMMENBRAUER, T., BAUER, C., SCZAKIEL, G., GROSSE, F. and DEPPERT, W., Negative feedback regulation of wild-type p53 biosynthesis. EMBO J., 14, 4442-4449 (1995).
28. OLINER, J.D., PIETENPOL, J.A., THIAGALINGAM, S., GYRUIS, J., KINZLER, K.W. and VOGELSTEIN, B., Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (Lond.), 362, 857-860 (1993).
29. RAFTER, J.J., CHILD, P., ANDERSON, A.M., ALDER, R., ENG, V. and BRUCE, W.R., Cellular toxicity of fecal water depends on diet. Amer. J. clin. Nutr., 45, 559-563 (1987).
30. REDDY, B.S., WEISBURGER, J.H. and WYNDER, E.L., Colon cancer: bile salts as tumour promoters. In: T.J. Saiga, A. Sivak and R.K. Boutwell (eds.), Carcinogenesis, pp. 453-464. Raven Press, New York (1978).
31. STADLER, J., YEUNG, K.S., FURRER, R., MARCON, N., HIMAL, H.S. and BRUCE, W.R., Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett., 38, 315-320 (1988).
32. TAKAHASHI, K. and SUZUKI, K., DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. Oncogene, 9, 183-188 (1994).
33. WILLIAMS, A.C., BROWNE, S.J., YEUDAL, W.A., PATERSON, I.C., MARSHALL, C.J., LANE, D.P. and PARASKEVA, C., Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8, 3063-3072 (1993).
34. WILLIAMS, A.C., HARPER, S.J. and PARASKEVA, C., Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res., 50, 4724-4730 (1990).
35. WINTERSBERGER, E. and MUDRAK, I., Sodium butyrate inhibits the synthesis of the transformation related protein p53 in 3T6 mouse fibroblasts. FEBS Lett., 1183, 326-330 (1984).
36. ZAUBERMAN, A., BARAK, Y., RAGIMOV, N., LEVY, N. and OREN, M., Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J., 12, 2799-2808 (1993).